Net Margin - Bioretec Oy (OMXH:BRETEC) - Alpha Spread
B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 2.68 EUR 0.37% Market Closed
Market Cap: 54.5m EUR
Have any thoughts about
Bioretec Oy?
Write Note

Net Margin
Bioretec Oy

-97%
Current
-158%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-97%
=
Net Income
-3.8m
/
Revenue
3.9m

Net Margin Across Competitors

Country FI
Market Cap 52.4m EUR
Net Margin
-97%
Country US
Market Cap 201.5B USD
Net Margin
14%
Country US
Market Cap 171B USD
Net Margin
28%
Country US
Market Cap 137.7B USD
Net Margin
16%
Country US
Market Cap 121.5B USD
Net Margin
12%
Country IE
Market Cap 113B USD
Net Margin
12%
Country US
Market Cap 67.3B USD
Net Margin
7%
Country DE
Market Cap 55.5B EUR
Net Margin
8%
Country US
Market Cap 42.1B USD
Net Margin
22%
Country US
Market Cap 41B USD
Net Margin
25%
Country US
Market Cap 40.8B USD
Net Margin
8%

Profitability Report

View the profitability report to see the full profitability analysis for Bioretec Oy.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-97%
=
Net Income
-3.8m
/
Revenue
3.9m
What is the Net Margin of Bioretec Oy?

Based on Bioretec Oy's most recent financial statements, the company has Net Margin of -97%.